Publication | Closed Access

Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)

AntibioticsTobramycin Polymeric NanoparticlesAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundMedicineClinical MicrobiologyAntimicrobial ResistanceDornase Alfa